Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
- PMID: 29024974
- PMCID: PMC5793729
- DOI: 10.1093/ijnp/pyx081
Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
Abstract
Major depressive disorder is an often chronic and recurring illness. Left untreated, major depressive disorder may result in progressive alterations in brain morphometry and circuit function. Recent findings, however, suggest that pharmacotherapy may halt and possibly reverse those effects. These findings, together with evidence that a delay in treatment is associated with poorer clinical outcomes, underscore the urgency of rapidly treating depression to full recovery. Early optimized treatment, using measurement-based care and customizing treatment to the individual patient, may afford the best possible outcomes for each patient. The aim of this article is to present recommendations for using a patient-centered approach to rapidly provide optimal pharmacological treatment to patients with major depressive disorder. Offering major depressive disorder treatment determined by individual patient characteristics (e.g., predominant symptoms, medical history, comorbidities), patient preferences and expectations, and, critically, their own definition of wellness provides the best opportunity for full functional recovery.
Keywords: depression; function; pharmacotherapy; treatment optimization.
© The Author(s) 2017. Published by Oxford University Press on behalf of CINP.
Figures
References
-
- Altamura AC, Serati M, Buoli M(2015)Is duration of illness really influencing outcome in major psychoses?Nord J Psychiatry 69:1–15. - PubMed
-
- American Academy of Professional Coders (2013)ICD-10 resource: coding for major depressive disorder http://cloud.aapc.com/documents/Depressive-Disorder-ICD-10-BH.pdf.
-
- American Psychiatric Association (2013)Major depressive disorder. In: Diagnostic and statistical manual of mental disorders (DSM-5), 5th ed, pp160–168. Washington, DC: American Psychiatric Association.
-
- Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A(2008)Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22:343–396. - PubMed
-
- Andrade C.(2015)Bioequivalence of generic drugs. J Clin Psychiatry 76:e1130–1131. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical